Liver defatting: An alternative approach to enable steatotic liver transplantation

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3176-3183

  Nativ, N I ^a   Maguire, T J ^a   Yarmush, G ^a   Brasaemle, D L ^b   Henry, S D ^c   Guarrera, J V ^c   Berthiaume, F ^a   Yarmush, M L ^a,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Defatting; fatty liver; ischemia reperfusion (I R); liver; machine perfusion; normothermic; steatosis; transplantation

Indexed keywords

BEZAFIBRATE; CERULENIN;

EXERCISE; FATTY LIVER; HUMAN; ISCHEMIC PRECONDITIONING; LIPID STORAGE; LIVER DEFATTING; LIVER PERFUSION; LIVER TRANSPLANTATION; MACHINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DIET; REPERFUSION INJURY; REVIEW; SYSTEMIC THERAPY; THERAPY EFFECT;

ANIMALS; FATTY LIVER; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; REPERFUSION INJURY; RISK FACTORS;

EID: 84870540633     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04288.x     Document Type: Review

References (40)

1. Cohen JC, Horton JD, Hobbs HH,. Human fatty liver disease: Old questions and new insights. Science 2011; 332: 1519-1523.
2. Fabbrini E, Sullivan S, Klein S,. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-689.
3. de Graaf EL, Kench J, Dilworth P, et al,. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol 2012; 27: 540-546.
4. Perez-Daga JA, Santoyo J, Suárez MA, et al,. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc 2006; 38: 2468-2470.
5. Spitzer AL, Lao OB, Dick AA, et al,. The biopsied donor liver: Incorporating macrosteatosis into high-risk donor assessment. Liver Transplant 2010; 16: 874-884.
6. Guarrera JV, Karim NA,. Liver preservation: Is there anything new yet Curr Opin Organ Transplant 2008; 13: 148-154.
7. Fryar CD, Ogden CL, Carroll MD,. Prevalence of overweight, obesity, and extreme obesity among adults: United States, Trends 1960-1962 through 2007-2008. Hyattsville, MD: Centers for Disease Control and Prevention. 2010. Available at: http://www.cdc.gov/nchs/data/hestat/obesity-adult-09-10/obesity-adult-09-10. html. Accessed April 18, 2012.
8. Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien P-A,. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006; 44: 694-701.
9. Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML,. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res 2009; 152: 54-60.
10. Taneja C, Prescott L, Koneru B,. Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells 1. Transplantation 1998; 65: 167-172.
11. Serafín A, Roselló-Catafau J, Prats N, Xaus C, Gelpí E, Peralta C,. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-601.
12. Ben Mosbah I, Roselló-Catafau J, Alfany-Fernandez I, et al,. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transplant 2010; 16: 163-171.
13. Vairetti M, Ferrigno A, Carlucci F, et al,. Subnormothermic machine perfusion protects steatotic livers against preservation injury: A potential for donor pool increase Liver Transplant 2009; 15: 20-29.
14. Selzner M, Clavien P-A,. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105,14.
15. Nakano H, Nagasaki H, Barama A, et al,. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997; 26: 670-678.
16. Sun C-K, Zhang X-Y, Zimmermann A, Davis G, Wheatley AM,. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker Rat1. Transplantation 2001; 72: 1625-1631.
17. Selzner M, RüDiger HA, Sindram D, Madden J, Clavien P-A,. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 1280-1288.
18. Laurens M, Scozzari G, Patrono D, et al,. Warm ischemia-reperfusion injury is decreased by tacrolimus in steatotic rat liver. Liver Transplant 2006; 12: 217-225.
19. Pierre-Alain Clavien SY, Sindram D, Rex C. B,. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162.
20. Yamagami K, Enders G, Schauer RJ, et al,. Heat-shock preconditioning protects fatty livers in genetically obese Zucker rats from microvascular perfusion failure after ischemia reperfusion. Transplant Int 2003; 16: 456-463.
21. Mokuno Y, Berthiaume F, Tompkins RG, Balis UJ, Yarmush ML,. Technique for expanding the donor liver pool: Heat shock preconditioning in a rat fatty liver model. Liver Transplant 2004; 10: 264-272.
22. Nakamuta M, Morizono S, Soejima Y, et al,. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005; 80: 608-612.
23. Clavien PA, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher A, El-Badry AM,. What is critical for liver surgery and partial liver transplantation: Size or quality Hepatology 2010; 52: 715-729.
24. Chavin KD, Fiorini RN, Shafizadeh S, et al,. Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am J Transplant 2004; 4: 1440-1447.
25. Guarrera JV, Henry SD, Samstein B, et al,. Hypothermic machine preservation in human liver transplantation: The first clinical series. Am J Transplant 2010; 10: 372-381.
26. Guarrera JV, Henry SD, Chen SWC, et al,. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: Preliminary results. J Surg Res 2011; 167: e365-e73.
27. Vogel T, Brockmann JG, Coussios C, Friend PJ,. The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev 2012; 26: 156-162.
28. Nagrath D, Xu H, Tanimura Y, et al,. Metabolic preconditioning of donor organs: Defatting fatty livers by normothermic perfusion ex vivo. Metab Eng 2009; 11: 274-283.
29. Tolboom H, Izamis M-L, Sharma N, et al,. Subnormothermic machine perfusion at both 20°C and 30°C recovers ischemic rat livers for successful transplantation. J Surg Res 2012; 175: 149-156.
30. Bessems M, Doorschodt BM, Kolkert JLP, et al,. Preservation of steatotic livers: A comparison between cold storage and machine perfusion preservation. Liver Transplant 2007; 13: 497-504.
31. Jamieson RW, Zilvetti M, Roy D, et al,. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation 2011; 92: 289-295.
32. Moers C, Smits JM, Maathuis MH, et al,. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7-19.
33. Dutta A, Vats P, Singh V, Sharma Y, Singh S, Singh S,. Impairment of mitochondrial β-oxidation in rats under cold-hypoxic environment. Int J Biometeorol 2009; 53: 397-407.
34. Lankester DL, Brown AM, Zammit VA,. Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes. J Lipid Res 1998; 39: 1889-1895.
35. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C,. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 1997; 272: 27218-27223.
36. Wang H, Bell M, Sreenevasan U, et al,. Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem 2011; 286: 15707-15715.
37. Wolins NE, Quaynor BK, Skinner JR, et al,. OXPAT/PAT-1 Is a PPAR-induced lipid droplet protein that promotes fatty acid utilization. Diabetes 2006; 55: 3418-3428.
38. Raubenheimer PJ, Nyirenda MJ, Walker BR,. A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes 2006; 55: 2015-2020.
39. Chan C, Berthiaume F, Lee K, Yarmush ML,. Metabolic flux analysis of hepatocyte function in hormone- and amino acid-supplemented plasma. Metab Eng 2003; 5: 1-15.
40. Murosaki S, Lee TR, Muroyama K, et al,. A combination of caffeine, arginine, soy isoflavones, and L-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J Nutr 2007; 137: 2252-2257.